Physician profile
Aman U Munir
NPI 1356388250
$911.10
in general payments reported to CMS, 2019-2025
19 companies · $264 in 2025
The $264 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163 · 2020: $21.04 · 2021: $31.01 · 2022: $40.76 · 2023: $249 · 2024: $142 · 2025: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $655.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $269.75 | 2023-2024 | Inspire |
| Astrazeneca Pharmaceuticals Lp | $118.08 | 2021-2025 | Tezspire, Breztri |
| Teva Pharmaceuticals USA, INC. | $93.09 | 2019 | |
| Glaxosmithkline, LLC. | $61.67 | 2022-2025 | Nucala, Shingrix, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.41 | 2019-2025 | Jascayd |
| Sunovion Pharmaceuticals INC. | $39.19 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $35.32 | 2025 | Dupixent |
| Genzyme Corporation | $35.12 | 2025 | |
| Verona Pharma, INC. | $33.95 | 2025 | Ohtuvayre |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $26.42 | 2025 | Caplyta |
| Breas Medical, INC. | $25.75 | 2024 | Vivo 45 Ls |
| Mallinckrodt Hospital Products INC. | $21.04 | 2020 | |
| Grifols USA, LLC | $19.74 | 2024 | Prolastin-C Liquid |
| Pfizer INC. | $18.90 | 2025 | |
| Insmed, INC. | $16.24 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $16.02 | 2025 | Zepbound |
| Harmony Biosciences LLC | $15.67 | 2025 | |
| Baxter Healthcare | $14.24 | 2025 | Hillrom - Vest System Model 105 Home Care |
| United Therapeutics Corporation | $2.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aman Munir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.